From Data Collection to Decision-Making in Clinical Trials

Clinical trials are generating unprecedented volumes of data, yet translating that data into timely, confident decisions remains a persistent challenge.

This executive summary captures insights from the 2026 SCOPE Roundtable featuring experts from Biogen, Veristat, Endeavor BioMedicines, Contraline, and EmVenio Clinical Research. Together, they explore how protocol design, real-time visibility, AI governance, and stronger system integration can help close the gap between data capture and operational clarity.

Access the full summary by filling out the form below.